U.S. drug and device companies on Thursday must begin keeping records of payments made to hospitals and doctors as part of new financial disclosure rules included in the Affordable Care Act. Industry stakeholders hope the information will allay fears that these relationships adversely affect patient outcomes or result in unethical behavior.

Related Summaries